Position in VERA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$23,722,987
-$11,437,325 QoQ
Shares Held
589,684
-15.1% QoQ
Ownership
0.821%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 98.17512430386445.ToString("F0")%
Shared 0.ToString("F0")%
None 1.8248756961355572.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,405,235 across 346 Biotechnology names. VERA ranks #69 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,722,987 | 589,684 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $35,160,312 | 694,319 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,253,115 | 490,472 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $9,289,236 | 394,280 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,452,923 | 227,016 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,279,017 | 30,244 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,051,731 | 136,917 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,509,214 | 179,912 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,630,553 | 200,152 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $591,867 | 38,483 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,304,039 | 95,116 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $171,074 | 10,659 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $681,614 | 87,837 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $999,929 | 51,676 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $732,999 | 34,397 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $291,988 | 21,454 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $366,537 | 15,604 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $318,154 | 11,907 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $113,138 | 6,521 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $82,371 | 6,212 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||